Nebenwirkungsmanagement in der Immunonkologie
<p>The immune oncological treatment approach uses immune checkpoint inhibitors to prevent tumor cells from shutting down the immune system, and thus from escaping immune response. Following the clinical success of immune checkpoint inhibitors, the number of approved immune oncological therapie...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | German |
| Published: |
2019
|
| In: |
Deutsche medizinische Wochenschrift
Year: 2019, Volume: 144, Issue: 05, Pages: 346-353 |
| ISSN: | 1439-4413 |
| DOI: | 10.1055/a-0739-8194 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1055/a-0739-8194 Verlag, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/a-0739-8194 
|
| Author Notes: | Niels Reinmuth, Michael Bitzer, Barbara Deschler-Baier, Jürgen R. Fischer, Jonas Kuon, Jan Leipe, Justyna Rawluk, Christian Schulz, Claus Peter Heußel, Michael Schultheiß |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1665039264 | ||
| 003 | DE-627 | ||
| 005 | 20241107133747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190509s2019 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1055/a-0739-8194 |2 doi | |
| 035 | |a (DE-627)1665039264 | ||
| 035 | |a (DE-599)KXP1665039264 | ||
| 035 | |a (OCoLC)1341212467 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Reinmuth, Niels |d 1970- |e VerfasserIn |0 (DE-588)122316592 |0 (DE-627)705858936 |0 (DE-576)293216266 |4 aut | |
| 245 | 1 | 0 | |a Nebenwirkungsmanagement in der Immunonkologie |c Niels Reinmuth, Michael Bitzer, Barbara Deschler-Baier, Jürgen R. Fischer, Jonas Kuon, Jan Leipe, Justyna Rawluk, Christian Schulz, Claus Peter Heußel, Michael Schultheiß |
| 264 | 1 | |c 2019 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.05.2019 | ||
| 520 | |a <p>The immune oncological treatment approach uses immune checkpoint inhibitors to prevent tumor cells from shutting down the immune system, and thus from escaping immune response. Following the clinical success of immune checkpoint inhibitors, the number of approved immune oncological therapies continues to increase. Response rates and overall survival with anti-PD-1/PD-L1 and CTLA-4 blockade could be further improved by combining both treatment approaches. However, checkpoint inhibition is associated with a unique spectrum of side effects termed immune-related adverse events. These typically occur 3 to 6 months after treatment start and resolve with adequate management procedures if detected early on. Therefore, profound patient education, sensitizing and monitoring are mandatory. We describe in this article selected frequent and rare adverse events that are clinically relevant. Furthermore, using case reports, interdisciplinary experts share their practice-based experience in the management of frequent pneumonic, endocrine, and gastro-intestinal immune-related adverse events.</p> | ||
| 700 | 1 | |a Bitzer, Michael |d 1966- |e VerfasserIn |0 (DE-588)129176877 |0 (DE-627)390358797 |0 (DE-576)188104933 |4 aut | |
| 700 | 1 | |a Deschler-Baier, Barbara |d 1972- |e VerfasserIn |0 (DE-588)122774264 |0 (DE-627)706038460 |0 (DE-576)293415528 |4 aut | |
| 700 | 1 | |a Fischer, Jürgen |d 1953- |e VerfasserIn |0 (DE-588)133724484 |0 (DE-627)691747725 |0 (DE-576)300052510 |4 aut | |
| 700 | 1 | |a Kuon, Jonas |e VerfasserIn |0 (DE-588)1166909484 |0 (DE-627)1030803730 |0 (DE-576)510963129 |4 aut | |
| 700 | 1 | |a Leipe, Jan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rawluk, Justyna |d 1968- |e VerfasserIn |0 (DE-588)129587222 |0 (DE-627)473361493 |0 (DE-576)188559574 |4 aut | |
| 700 | 1 | |a Schulz, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heußel, Claus Peter |e VerfasserIn |0 (DE-588)1048631389 |0 (DE-627)780769422 |0 (DE-576)40288146X |4 aut | |
| 700 | 1 | |a Schultheiß, Michael |d 1978- |e VerfasserIn |0 (DE-588)132083639 |0 (DE-627)517884747 |0 (DE-576)298934639 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Deutsche medizinische Wochenschrift |d Stuttgart : Thieme, 1875 |g 144(2019), 05, Seite 346-353 |h Online-Ressource |w (DE-627)325298084 |w (DE-600)2035474-5 |w (DE-576)252791142 |x 1439-4413 |7 nnas |a Nebenwirkungsmanagement in der Immunonkologie |
| 773 | 1 | 8 | |g volume:144 |g year:2019 |g number:05 |g pages:346-353 |g extent:8 |a Nebenwirkungsmanagement in der Immunonkologie |
| 856 | 4 | 0 | |u https://doi.org/10.1055/a-0739-8194 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.thieme-connect.de/DOI/DOI?10.1055/a-0739-8194 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190509 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1048631389 |a Heußel, Claus Peter |m 1048631389:Heußel, Claus Peter |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1048631389 |e 950000PH1048631389 |e 950900PH1048631389 |e 50000PH1048631389 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 9 | ||
| 998 | |g 1166909484 |a Kuon, Jonas |m 1166909484:Kuon, Jonas |d 910000 |d 950000 |d 950900 |e 910000PK1166909484 |e 950000PK1166909484 |e 950900PK1166909484 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 5 | ||
| 998 | |g 122316592 |a Reinmuth, Niels |m 122316592:Reinmuth, Niels |d 50000 |e 50000PR122316592 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1665039264 |e 3472356308 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"part":{"pages":"346-353","year":"2019","extent":"8","volume":"144","issue":"05","text":"144(2019), 05, Seite 346-353"},"physDesc":[{"extent":"Online-Ressource"}],"language":["ger"],"origin":[{"publisher":"Thieme ; [Verlag nicht ermittelbar]","dateIssuedDisp":"1875-","dateIssuedKey":"1875","publisherPlace":"Stuttgart ; [Wechselnde Verlagsorte]"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 30.10.2013"],"disp":"Nebenwirkungsmanagement in der ImmunonkologieDeutsche medizinische Wochenschrift","id":{"issn":["1439-4413"],"zdb":["2035474-5"],"doi":["10.1055/s-00000011"],"eki":["325298084"]},"title":[{"title":"Deutsche medizinische Wochenschrift","title_sort":"Deutsche medizinische Wochenschrift","subtitle":"DMW ; Organ der Deutschen Gesellschaft für Innere Medizin (DGIM) ; Organ der Gesellschaft Deutscher Naturforscher und Ärzte (GDNÄ)"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"Deutsche Gesellschaft für Innere Medizin"},{"role":"isb","display":"Gesellschaft Deutscher Naturforscher und Ärzte","roleDisplay":"Herausgebendes Organ"}],"titleAlt":[{"title":"DMW"}],"pubHistory":["1.1875,Sept. - 70.1944,39/40; 71.1946,Mai -"],"recId":"325298084"}],"person":[{"display":"Reinmuth, Niels","role":"aut","given":"Niels","roleDisplay":"VerfasserIn","family":"Reinmuth"},{"display":"Bitzer, Michael","role":"aut","given":"Michael","family":"Bitzer","roleDisplay":"VerfasserIn"},{"given":"Barbara","role":"aut","display":"Deschler-Baier, Barbara","roleDisplay":"VerfasserIn","family":"Deschler-Baier"},{"family":"Fischer","roleDisplay":"VerfasserIn","role":"aut","display":"Fischer, Jürgen","given":"Jürgen"},{"roleDisplay":"VerfasserIn","family":"Kuon","given":"Jonas","role":"aut","display":"Kuon, Jonas"},{"family":"Leipe","roleDisplay":"VerfasserIn","given":"Jan","display":"Leipe, Jan","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Rawluk","display":"Rawluk, Justyna","role":"aut","given":"Justyna"},{"given":"Christian","display":"Schulz, Christian","role":"aut","roleDisplay":"VerfasserIn","family":"Schulz"},{"given":"Claus Peter","role":"aut","display":"Heußel, Claus Peter","family":"Heußel","roleDisplay":"VerfasserIn"},{"display":"Schultheiß, Michael","role":"aut","given":"Michael","roleDisplay":"VerfasserIn","family":"Schultheiß"}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Niels Reinmuth, Michael Bitzer, Barbara Deschler-Baier, Jürgen R. Fischer, Jonas Kuon, Jan Leipe, Justyna Rawluk, Christian Schulz, Claus Peter Heußel, Michael Schultheiß"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["ger"],"note":["Gesehen am 09.05.2019"],"recId":"1665039264","id":{"eki":["1665039264"],"doi":["10.1055/a-0739-8194"]},"title":[{"title":"Nebenwirkungsmanagement in der Immunonkologie","title_sort":"Nebenwirkungsmanagement in der Immunonkologie"}]} | ||
| SRT | |a REINMUTHNINEBENWIRKU2019 | ||